Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
217 Resmetirom (MGL-3196) is a selective THR- agonist and is currently under clinical phase 2/3 trials (NCT02912260 and NCT03900429)
Retatrutide shows comparable glycemic improvements
Microdosing allows you to start the medication at a very low dose and increase its dosage gradually to improve the bodys tolerance while still gaining some therapeutic benefits
Retatrutides pricing will likely be competitive with these products
Ozempic comes in pre-loaded syringes with a dial to change dosages
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
